Evidence map›Paper›PMID 38082220›Full record

ArticleBMC bioinformatics2023

primerJinn: a tool for rationally designing multiplex PCR primer sets for amplicon sequencing and performing in silico PCR.

Jason D Limberis, John Z Metcalfe

Open access · goldAbstract read
In one paragraph

Article in BMC bioinformatics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Primer design through submodular function estimation.Bioinformatics (Oxford, England) · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Marker discovery in the large.Bioinformatics advances · 2024
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Jason D LimberisDivision of Pulmonary and Critical Care Medicine, Trauma Centre, Zuckerberg San Francisco General Hospital, University of California, San Francisco, San Francisco, CA, USA. Jason.Limberis@ucsf.edu.
John Z MetcalfeDivision of Pulmonary and Critical Care Medicine, Trauma Centre, Zuckerberg San Francisco General Hospital, University of California, San Francisco, San Francisco, CA, USA.
University of California, San Francisco · US

Funding

Handheld and population-based sequencing for rapid detection of new and repurposed drug resistance in M. tuberculosisR01AI153213 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI David M Engelthaler, John Zapata Metcalfe · 2021 to 2026
$3.7M
A novel cartridge-based sequencing solution for decentralized M. tuberculosis resistance detectionR01AI177637 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Soumitesh Chakravorty, John Zapata Metcalfe · 2023 to 2026
$2.8M
NIAID NIH HHS R01 AI153213NIAID NIH HHS R01 AI177637
6 · The paper itself

Abstract

backgroundMultiplex PCR amplifies numerous targets in a single tube reaction and is essential in molecular biology and clinical diagnostics. One of its most important applications is in the targeted sequencing of pathogens. Despite this importance, few tools are available for designing multiplex primers.

resultsWe developed primerJinn, a tool that designs a set of multiplex primers and allows for the in silico PCR evaluation of primer sets against numerous input genomes. We used primerJinn to create a multiplex PCR for the sequencing of drug resistance-conferring gene regions from Mycobacterium tuberculosis, which were then successfully sequenced.

conclusionsprimerJinn provides a user-friendly, efficient, and accurate method for designing multiplex PCR primers for targeted sequencing and performing in silico PCR. It can be used for various applications in molecular biology and bioinformatics research, including the design of assays for amplifying and sequencing drug-resistance-conferring regions in important pathogens.

Indexed as

Multiplex Polymerase Chain ReactionMycobacterium tuberculosisBase SequenceDNA PrimersSequence AnalysisDNA PrimersMultiplex PCRPCRPrimer designTargeted sequencing

Identifiers

PMID38082220
PMCPMC10714587
OpenAlexW4389580827

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.